Tesla Inc.'s Model 3 Deliveries Start This Week
For Tesla investors, all eyes are on Tesla's Model 3 launch on Friday.
Schlumberger's Second-Quarter Earnings Rebound Slightly, but Remain in the Loss Column
Global oil and gas activity hasn't fully recovered, but at least it is no longer declining.
Why Big Oil Can’t Make the Renewable Energy Transition
Today's fossil fuel giants can see that wind and solar power will be eating their lunch tomorrow, but knowing the disruption is coming doesn't mean they can pivot to meet it.
3 Cheap High-Yield Dividend Stocks You Can Buy Right Now
If you consider the long term prospects of Enterprise Products Partners, STAG Industrial, and Brookfield Renewable Partners, then their current stock prices look sensible.
iPhone sales, revenue, and gross margin will give investors key insight into Apple's business.
Square stock has nearly doubled this year. Don't overlook this company any longer.
Your household fiscal health is just one piece in a much bigger puzzle, but it’s a piece that holistically interacts with all the other parts and should be treated that way.
Decades-dominating performance can be found in First Solar, Dunkin' Brands, and Boyd Gaming.
These new hires aren't going to stop the competition.
Management is top-notch, but that doesn't mean the stock is a no-brainer.
Employees need the help, and employers will benefit from providing it. But exactly what types of assistance should they focus on?
Believe it or not, the top answer is the same across every demographic, but there are distinct generational issues as well.
Infinera’s double-digit rally this year doesn’t seem justified.
You may think the answer to that first question is so obvious it doesn’t need to be explicitly states -- but that’s because so many people have their own definitions.
Novavax's highly anticipated clinical update fails to impress.
On a down day for the market indexes, WebMD announced a buyout and Hasbro stock fell despite strong Q2 earnings.
Shares of the toy-maker headed south as sales growth was not as strong as expected.
McCormick's acquisition of French's mustard may be expensive, but it will generate real shareholder value.
These stocks fell sharply even though the market on the whole was close to flat. Find out why.
Trial results showing mid-stage success for a drug targeting a rare form of chronic kidney disease are sparking interest in the clinical-stage biotech stock.
Fairmount Santrol Holdings is the latest frack-sand producer adding capacity in that red-hot oil play, which could lead to a glut of sand in the coming months.
The global payments network is collecting an ever-rising toll as the world moves towards digital payments and away from cash and checks.
High-paying dividend stocks come in all shapes and sizes. Here are a few to consider in July.